InfuSystem Holdings, Inc. President and CEO Carrie Lachance filed a Form 4 on November 19, 2026, disclosing transactions in common stock on November 17, 2026, including the vesting of 50,000 performance-based restricted stock units and the withholding of 19,675 shares for tax obligations.

Key Highlights

  • RSU vesting: 50,000 performance-based restricted stock units, originally granted on May 16, 2025, vested on November 17, 2026, at a price of $0, according to the filing.
  • Tax withholding: 19,675 shares of common stock were withheld by the issuer at $14.79 per share to cover the tax liability associated with the vesting.
  • Resulting ownership: Following both transactions, Lachance directly beneficially owned 297,648 shares of common stock.
  • Prior holdings: The filing reports a pre-transaction holding of 267,323 shares, which the filing notes includes an additional 932 shares acquired through the company's Employee Stock Purchase Plan.
  • Reporting person role: Carrie Lachance is identified as both a Director and President and CEO of InfuSystem Holdings, Inc., listed on NYSE:INFU.

Lachance RSU Vesting and Share Withholding Details at InfuSystem

According to the Form 4 filed on November 19, 2026, Carrie Lachance, President and CEO and a Director of InfuSystem Holdings, Inc. (NYSE:INFU), reported two transactions in the company's common stock on November 17, 2026. The first was the acquisition of 50,000 shares resulting from the vesting of performance-based restricted stock units that had been granted on May 16, 2025. The shares were acquired at a price of $0, as disclosed in the filing.

The second transaction, coded "F" in the filing, involved the disposition of 19,675 shares at $14.79 per share. The filing describes this as "the withholding of the Issuer's common stock for the tax liability associated with the vesting and settlement of the common stock issued on November 17, 2026." Both transactions are reported as direct ownership.

Before the reported transactions, Lachance held 267,323 shares, a figure the filing notes includes 932 shares acquired through the company's Employee Stock Purchase Plan. After the vesting of 50,000 shares and the withholding of 19,675 shares, her directly held beneficial ownership stood at 297,648 shares, as reported in the filing. The Form 4 was signed by Kevin Whitman as attorney-in-fact for Carrie Lachance on November 19, 2026.

What Was Disclosed

The filing reports two November 17, 2026 transactions by InfuSystem CEO Carrie Lachance: the vesting of 50,000 performance-based RSUs granted May 16, 2025, and the withholding of 19,675 shares at $14.79 for tax purposes, leaving her with 297,648 directly owned shares.